The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.
World-renowned experts from leading cancer centers are at the forefront of our research.
Open in Twitter
Parker Institute
@parkerici
How we're using modern data science to #solvecancer. Meet our Informatics team: https://t.co/xElj1sxk1V
#CIM18… https://t.co/2unUar0BhR
20 hours ago
Parker Institute
@parkerici
How we're using modern data science to #solvecancer. Meet our Informatics team: https://t.co/xElj1sxk1V
#CIM18… https://t.co/2unUar0BhR
20 hours ago
Open in Twitter
Parker Institute
@parkerici
New study: Crystal Mackall of @StanfordMed, Danny Wells of PICI and others demonstrate effectiveness of NY-ESO1 TCR… https://t.co/lYIdQuWClr
2 days ago
Parker Institute
@parkerici
New study: Crystal Mackall of @StanfordMed, Danny Wells of PICI and others demonstrate effectiveness of NY-ESO1 TCR… https://t.co/lYIdQuWClr
2 days ago
Open in Twitter
Parker Institute
@parkerici
RT @CancerResearch: Not all T cells are created equal, as Drs. Wherry and Masopust found while CRI postdoctoral fellows in the Ahmed lab at…
2 days ago
Parker Institute
@parkerici
RT @CancerResearch: Not all T cells are created equal, as Drs. Wherry and Masopust found while CRI postdoctoral fellows in the Ahmed lab at…
2 days ago